Source

Commission Implementing Regulation (EU) 2018/1266 of 20 September 2018 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 1-decanol, 6-benzyladenine, aluminium sulfate, azadirachtin, bupirimate, carboxin, clethodim, cycloxydim, dazomet, diclofop, dithianon, dodine, fenazaquin, fluometuron, flutriafol, hexythiazox, hymexazol, indolylbutyric acid, isoxaben, lime sulphur, metaldehyde, paclobutrazol, pencycuron, sintofen, tau-fluvalinate and tebufenozide (Text with EEA relevance.)

Implementing Regulation (EU) 2018/1266 · Regulation · 3 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Open ↗

The Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.

Article 2

Open ↗

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .

Supplementary provisions

ANNEXSupplementary provisions

Open ↗

ANNEX Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows: (1) in the sixth column, expiration of approval, of row 316, Cycloxydim, the date is replaced by ‘31 May 2023’; (2) in the sixth column, expiration of approval, of row 317, 6-Benzyladenine, the date is replaced by ‘31 May 2024’; (3) in the sixth column, expiration of approval, of row 322, Hymexazol, the date is replaced by ‘31 May 2023’; (4) in the sixth column, expiration of approval, of row 323, Dodine, the date is replaced by ‘31 May 2024’; (5) in the sixth column, expiration of approval, of row 326, Indolylbutyric acid, the date is replaced by ‘31 May 2023’; (6) in the sixth column, expiration of approval, of row 328, Tau-fluvalinate, the date is replaced by ‘31 May 2024’; (7) in the sixth column, expiration of approval, of row 329, Clethodim, the date is replaced by ‘31 May 2023’; (8) in the sixth column, expiration of approval, of row 330, Bupirimate, the date is replaced by ‘31 May 2024’; (9) in the sixth column, expiration of approval, of row 333, 1-decanol, the date is replaced by ‘31 May 2024’; (10) in the sixth column, expiration of approval, of row 334, Isoxaben, the date is replaced by ‘31 May 2024’; (11) in the sixth column, expiration of approval, of row 335, Fluometuron, the date is replaced by ‘31 May 2024’; (12) in the sixth column, expiration of approval, of row 337, Carboxin, the date is replaced by ‘31 May 2023’; (13) in the sixth column, expiration of approval, of row 339, Dazomet, the date is replaced by ‘31 May 2023’; (14) in the sixth column, expiration of approval, of row 340, Metaldehyde, the date is replaced by ‘31 May 2023’; (15) in the sixth column, expiration of approval, of row 341, Sintofen, the date is replaced by ‘31 May 2024’; (16) in the sixth column, expiration of approval, of row 342, Fenazaquin, the date is replaced by ‘31 May 2023’; (17) in the sixth column, expiration of approval, of row 343, Azadirachtin, the date is replaced by ‘31 May 2024’; (18) in the sixth column, expiration of approval, of row 344, Diclofop, the date is replaced by ‘31 May 2023’; (19) in the sixth column, expiration of approval, of row 345, Lime sulphur, the date is replaced by ‘31 May 2024’; (20) in the sixth column, expiration of approval, of row 346, Aluminium sulfate, the date is replaced by ‘31 May 2024’; (21) in the sixth column, expiration of approval, of row 348, Paclobutrazol, the date is replaced by ‘31 May 2023’; (22) in the sixth column, expiration of approval, of row 349, Pencycuron, the date is replaced by ‘31 May 2024’; (23) in the sixth column, expiration of approval, of row 350, Tebufenozide, the date is replaced by ‘31 May 2024’; (24) in the sixth column, expiration of approval, of row 351, Dithianon, the date is replaced by ‘31 May 2024’; (25) in the sixth column, expiration of approval, of row 352, Hexythiazox, the date is replaced by ‘31 May 2024’; (26) in the sixth column, expiration of approval, of row 353, Flutriafol, the date is replaced by ‘31 May 2024’.

Other acts of the same type

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

What to look at next

Browse all EU Legal ActsEvery instrument by type and year, full text free to read section by sectionEuropean Union legislation EU Legal Acts by type and yearGrouped by instrument type and year of enactment, so you can find others of the same kindBrowse by type and year European Union: what this database coversWhich datasets are here, which official source they come from, and how current they areEuropean Union overview